85 related articles for article (PubMed ID: 28043624)
1. New insights into the mechanism of action of pyrazinamide, implications for susceptibility testing, and future regimens.
Anthony RM; den Hertog A; Mansjö M; Werngren J
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S71-S72. PubMed ID: 28043624
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene.
Bhuju S; Fonseca Lde S; Marsico AG; de Oliveira Vieira GB; Sobral LF; Stehr M; Singh M; Saad MH
Infect Genet Evol; 2013 Oct; 19():1-6. PubMed ID: 23770140
[TBL] [Abstract][Full Text] [Related]
3. Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis.
Zhang S; Chen J; Shi W; Liu W; Zhang W; Zhang Y
Emerg Microbes Infect; 2013 Jun; 2(6):e34. PubMed ID: 26038471
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Pyrazinamide Action and Resistance.
Zhang Y; Shi W; Zhang W; Mitchison D
Microbiol Spectr; 2014 Aug; 2(4):MGM2-0023-2013. PubMed ID: 26104205
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Pyrazinamide Action and Resistance.
Zhang Y; Shi W; Zhang W; Mitchison D
Microbiol Spectr; 2013; 2(4):1-12. PubMed ID: 25530919
[TBL] [Abstract][Full Text] [Related]
6. Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis.
Shi W; Chen J; Feng J; Cui P; Zhang S; Weng X; Zhang W; Zhang Y
Emerg Microbes Infect; 2014 Aug; 3(8):e58. PubMed ID: 26038753
[TBL] [Abstract][Full Text] [Related]
7. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing.
Shenai S; Rodrigues C; Sadani M; Sukhadia N; Mehta A
Indian J Tuberc; 2009 Apr; 56(2):82-90. PubMed ID: 19810590
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, China.
Xia Q; Zhao LL; Li F; Fan YM; Chen YY; Wu BB; Liu ZW; Pan AZ; Zhu M
Antimicrob Agents Chemother; 2015 Mar; 59(3):1690-5. PubMed ID: 25583712
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide].
Hong CY; Wang F; Gui J; Liu XL
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 May; 46(5):436-9. PubMed ID: 22883731
[TBL] [Abstract][Full Text] [Related]
10. The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide.
Daneau G; Gumusboga M; De Rijk P; Trebucq A; Rigouts L; Van Deun A; de Jong BC
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S46-S47. PubMed ID: 28043604
[TBL] [Abstract][Full Text] [Related]
11. Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA, and panD gene mutations.
Gu Y; Yu X; Jiang G; Wang X; Ma Y; Li Y; Huang H
Diagn Microbiol Infect Dis; 2016 Mar; 84(3):207-11. PubMed ID: 26775806
[TBL] [Abstract][Full Text] [Related]
12. Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience.
Hoffner S; Angeby K; Sturegård E; Jönsson B; Johansson A; Sellin M; Werngren J
Int J Tuberc Lung Dis; 2013 Nov; 17(11):1486-90. PubMed ID: 24125455
[TBL] [Abstract][Full Text] [Related]
13. Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea.
Kim HJ; Kwak HK; Lee J; Yun YJ; Lee JS; Lee MS; Min SY; Park SK; Kang HS; Maeng YH; Kim SY; Kim SY; Kook YH; Kim YR; Lee KH
Int J Tuberc Lung Dis; 2012 Jan; 16(1):98-103. PubMed ID: 22236853
[TBL] [Abstract][Full Text] [Related]
14. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.
Singh P; Mishra AK; Malonia SK; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM
J Commun Dis; 2006 Mar; 38(3):288-98. PubMed ID: 17373362
[TBL] [Abstract][Full Text] [Related]
15. Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
Rajendran V; Sethumadhavan R
J Biomol Struct Dyn; 2014; 32(2):209-21. PubMed ID: 23383724
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan.
Akhmetova A; Kozhamkulov U; Bismilda V; Chingissova L; Abildaev T; Dymova M; Filipenko M; Ramanculov E
Int J Tuberc Lung Dis; 2015 Feb; 19(2):179-84. PubMed ID: 25574916
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of the pncA gene in Mycobacterium tuberculosis isolates from Gauteng, South Africa.
Bishop KS; Blumberg L; Trollip AP; Smith AN; Roux L; York DF; Kiepiela P
Int J Tuberc Lung Dis; 2001 Oct; 5(10):952-7. PubMed ID: 11605890
[TBL] [Abstract][Full Text] [Related]
18. 'Z(S)-MDR-TB' versus 'Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility.
Zhang Y; Chiu Chang K; Leung CC; Wai Yew W; Gicquel B; Fallows D; Kaplan G; Chaisson RE; Zhang W
Emerg Microbes Infect; 2012 Jul; 1(7):e5. PubMed ID: 26038418
[TBL] [Abstract][Full Text] [Related]
19. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.
Lee KW; Lee JM; Jung KS
J Korean Med Sci; 2001 Oct; 16(5):537-43. PubMed ID: 11641519
[TBL] [Abstract][Full Text] [Related]
20. Structural Dynamics Behind Clinical Mutants of PncA-Asp12Ala, Pro54Leu, and His57Pro of
Mehmood A; Khan MT; Kaushik AC; Khan AS; Irfan M; Wei DQ
Front Bioeng Biotechnol; 2019; 7():404. PubMed ID: 31921809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
